Joseph J. McDonald - Concepedia

Author

Joseph J. McDonald

Also Known As

J J McDonald, JOSEPH J. MCDONALD, JOSEPH J. McDONALD, Joseph J McDonald, Joseph J. McDonald, Joseph J. Mcdonald, Joseph McDonald, McDonald, Joseph

Publications

3.9K

Citations

H-Index

111

Concepts

All Affiliations

Pfizer (United States)Monsanto (United States)American University of Beirut

About

Joseph J. McDonald is an author at Pfizer (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	31	2.9K
2	Natural Sciences	14	16	2.4K
3	Engineering	1	1	125
4	Health Sciences	1	1	10
5	Humanities	1	1	12

Joseph J. McDonald

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents Ravi G. Kurumbail, Anna M. Stevens, James K. Gierse, Nature InflammationMedicinal ChemistryAnti-inflammatoryBiochemistryMedicine	1996	1.9K
A Single Amino Acid Difference between Cyclooxygenase-1 (COX-1) and −2 (COX-2) Reverses the Selectivity of COX-2 Specific Inhibitors James K. Gierse, Joseph J. McDonald, Scott D. Hauser, Journal of Biological Chemistry	1996	410
Assessment of Docking Poses: Interactions-Based Accuracy Classification (IBAC) versus Crystal Structure Deviations Romano T. Kroemer, Anna Vulpetti, Joseph J. McDonald, Journal of Chemical Information and Computer Sciences Crystal StructureDrug TargetEngineering3D Pose EstimationMolecular Biology	2004	125
Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor Yiqing Feng, John J. Likos, Leiming Zhu, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics Protein ChemistryCatalytic DomainHydroxamic Acid InhibitorBackbone DynamicsBiochemistry	2002	100
Orally Active MMP-1 Sparing α-Tetrahydropyranyl and α-Piperidinyl Sulfone Matrix Metalloproteinase (MMP) Inhibitors with Efficacy in Cancer, Arthritis, and Cardiovascular Disease Daniel P. Becker, Thomas E. Barta, Louis J. Bedell, Journal of Medicinal Chemistry Spare Mmp-1PharmacotherapyPharmaceutical ChemistryInflammatory ArthritisTumor Biology	2010	97
Crystal structure of the SALL4–pomalidomide–cereblon–DDB1 complex Mary E. Matyskiela, Thomas Clayton, Xinde Zheng, Nature Structural & Molecular Biology Crystal StructureNatural SciencesMolecular BiologyStructure ElucidationChemistry	2020	96
Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease Srinivasan Nagarajan, Gary A. De Crescenzo, Daniel P. Getman, Bioorganic & Medicinal Chemistry Hiv-1 ProteaseBiochemistryMedicineAntiviral Drug DevelopmentAntiviral Drug	2003	94
Variations in the origin of arteries derived from the aortic arch, in American whites and negroes Joseph J. McDonald, Barry J. Anson American Journal of Physical Anthropology Aortic ArchVascular DiseaseAortic Arch SurgeryCardiovascular DiseaseVascular Adaptation	1940	66
Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic Modality Philip P. Chamberlain, Laura Akullian D’Agostino, J. Michael Ellis, ACS Medicinal Chemistry Letters	2019	66
Synthesis and Structure−Activity Relationships of β- and α-Piperidine Sulfone Hydroxamic Acid Matrix Metalloproteinase Inhibitors with Oral Antitumor Efficacy Daniel P. Becker, Clara I. Villamil, Thomas E. Barta, Journal of Medicinal Chemistry Pharmaceutical ScienceBreast OncologyImmunologyPharmacotherapyPharmaceutical Chemistry	2005	64

Page 1